Inspira Technologies successfully treats first patient with FDA-cleared INSPIRA ART100 system

From GlobeNewswire: 2025-04-07 08:30:00

In a groundbreaking move, Inspira™ Technologies successfully completed the first human treatment using its FDA-cleared INSPIRA™ ART100 system at Westchester Medical Center in New York State. The system provided comprehensive heart and lung support during the critical procedure, showcasing its reliability and effectiveness. Dr. David Spielvogel praised the system’s performance and seamless transition, highlighting its potential for broader adoption. This milestone marks a significant advancement in extracorporeal support technology, with Inspira committed to expanding critical care solutions. The installation and training program for the INSPIRA ART100 was led by Glo-Med Networks Inc., marking a promising future for patient care.

Inspira Technologies is at the forefront of developing innovative respiratory support and diagnostics technologies, with the INSPIRA ART500 system aiming to revolutionize critical care. The FDA-cleared INSPIRA ART100 system has received regulatory approvals for Cardiopulmonary Bypass procedures in the U.S. and Israel. Additionally, the Company’s HYLA™ blood sensor technology offers continuous blood monitoring without invasive blood draws. With a pipeline of products in development, Inspira is dedicated to advancing critical care solutions for patients worldwide. Glo-Med Networks Inc., a key partner in delivering healthcare solutions, plays a pivotal role in expanding access to medical products and services globally.



Read more at GlobeNewswire: Inspira Technologies Announces Successful Treatment of